Marialena Mouzaki, MD, MSc
- Medical Director, Advanced Nutrition Services
- Associate Director, Steatohepatitis Program
- Fellowship Program Director, Advanced Nutrition Fellowship
- Professor, UC Department of Pediatrics
- marialena.mouzaki@cchmc.org
- Board Certified
About
MD: National and Kapodistrian Medical School of Athens, Greece, 2005.
Residency: General Pediatrics, Penn State Children's Hospital, Hershey, PA, 2009.
Clinical Fellowship: Hospital for Sick Children, Toronto, ON, Canada, 2010.
Clinical/Research Fellowship: Hospital for Sick Children, Toronto, ON, Canada, 2012.
Teaching Scholars Program: Hospital for Sick Children, Toronto, ON, Canada, 2016.
MSc: University of Toronto, Toronto, ON, Canada, 2012.
Certification: General Pediatrics, 2009; Pediatric Gastroenterology, 2013; National Board of Physician Nutrition Specialists, 2018; National Board of Physician Nutrition Scientists, 2018; Diplomat of the American Board of Obesity Medicine, 2022.
Interests
Nutrition and specifically MASLD; pediatric gastroenterology
Services and Specialties
Interests
Pediatric MASLD
Research Areas
Additional Languages
Greek
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
Pediatric Obesity Pharmacotherapy. Gastroenterology Clinics of North America. 2025; 54:745-760.
Maternal metabolic dysfunction-associated steatotic liver disease during pregnancy and its impact on offspring steatosis. Clinical Nutrition ESPEN. 2025; 70:327-335.
Call to action-Pediatric MASLD requires immediate attention to curb health crisis. Hepatology. 2025; 82:1341-1351.
Longitudinal response to standard of care in pediatric metabolic dysfunction-associated steatotic liver disease: Rates of improvement and worsening, and factors associated with outcomes. Hepatology. 2025; 82:1198-1210.
Sonographic evidence of hepatic steatosis is highly prevalent in at-risk children under 4 years of age. Journal of Pediatric Gastroenterology and Nutrition. 2025; 81:679-682.
Elevated Alpha-Fetoprotein Levels in Children with Metabolic Dysfunction-Associated Liver Disease. Childhood Obesity. 2025; 21:544-548.
Sa1442: LIPIDOMIC AND METABOLOMIC INSIGHTS INTO PEDIATRIC CHRONIC PANCREATITIS: DECIPHERING THE METABOLIC LANDSCAPE. Gastroenterology. 2025; 169:s-471.
Pediatric endoscopic ultrasound-guided liver biopsy: 3-year experience. Journal of Pediatric Gastroenterology and Nutrition. 2025; 80:920-925.
Longitudinal evaluation of pediatric and young adult metabolic dysfunction-associated steatotic liver disease defined by MR elastography. European Radiology. 2025; 35:2474-2486.
Topiramate treatment of pediatric metabolic dysfunction-associated steatotic liver disease: A descriptive cohort study. Journal of Parenteral and Enteral Nutrition. 2025; 49:308-313.
From the Blog
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey